SJS Investment Consulting’s GeneDx Holdings WGS Stock Holding History

SJS Investment Consulting’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.52K	Buy	21 +10	+91%	+$775	﹤0.01%	2328
2026 Q2	$756	Buy	+11	New	+$625	﹤0.01%	2122
2026 Q1	–	Sell	-3,000	Closed	-$390K	–	2581
2025 Q4	$390K	Hold	3,000	–	–	0.05%	94
2025 Q3	$323K	Sell	3,000 -1,280	-30%	-$139K	0.04%	96
2025 Q2	$395K	Buy	4,280 +709	+20%	+$55.7K	0.06%	69
2025 Q1	$316K	Hold	3,571	–	–	0.05%	71
2024 Q4	$274K	Hold	3,571	–	–	0.05%	76
2024 Q3	$152K	Buy	+3,571	New	+$121K	0.03%	112

Other funds holding WGS

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

SJS Investment Consulting's WGS Position: Q3 2026 in Review

SJS Investment Consulting increased its GeneDx Holdings (WGS) stake by 91% in Q3 2026, buying an estimated $775 and bringing the position to 21 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

SJS Investment Consulting first reported a position in WGS in Q3 2024 and has held it in 8 quarters since. The position peaked at $395K in Q2 2025. 114 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

SJS Investment Consulting held 21 shares of GeneDx Holdings worth $1.52K as of Q3 2026.
SJS Investment Consulting bought 10 GeneDx Holdings shares in Q3 2026, an estimated $775.
GeneDx Holdings made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2328 holding.
SJS Investment Consulting first reported a position in GeneDx Holdings in Q3 2024 and has held it in 8 quarters since.
SJS Investment Consulting's GeneDx Holdings position peaked at $395K in Q2 2025.
114 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.